Back to search
Publication
Long lasting BCG protection against leprosy.
Abstract
BACKGROUND: BCG vaccine protects against leprosy.
OBJECTIVES: Estimate BCG protection against leprosy by age by age.
METHODS: A case control study with 226 cases of leprosy and 857 controls. BCG vaccination was ascertained via examination of BCG scars. Protection is presented for three age groups.
RESULTS: BCG protection against leprosy was 86% (95% CI: 77-92%) in the age group 18-29; 54% (95% CI: -37% to 85%) in the age group 30-39 and 32% (95% CI: -3% to 56%) in those aged 40 or more.
CONCLUSIONS: BCG efficacy against leprosy may well last for three decades and possibly even longer. BCG vaccination must have contributed to worldwide reduction in leprosy incidence.
More information
Type
Journal Article